Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Revenue (2024 - 2025)

Prime Medicine's Revenue history spans 2 years, with the latest figure at $838000.0 for Q4 2025.

  • For Q4 2025, Revenue fell 61.61% year-over-year to $838000.0; the TTM value through Dec 2025 reached $4.6 million, up 55.28%, while the annual FY2025 figure was $4.6 million, 55.28% up from the prior year.
  • Revenue reached $838000.0 in Q4 2025 per PRME's latest filing, down from $1.2 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $2.2 million in Q4 2024 to a low of $209000.0 in Q3 2024.